rhBMP-2复合明胶海绵修复兔桡骨极限骨缺损剂量依赖性的研究
DOI:
作者:
作者单位:

1.空军军医大学西京医院骨科,武警湖北省总队医院骨科;2.空军军医大学西京医院骨科

作者简介:

通讯作者:

中图分类号:

R318

基金项目:

战创伤损伤修复技术与器械研究


Dose-effect relationship of rhBMP-2 combined with absorbable collagen sponge in repairing radial defect in rabbits
Author:
Affiliation:

1.Department of Orthopedics, Xijing Hospital, Air Force Military Medical University;2.Department of Orthopedics, Hubei Corps Hospital of Armed Police

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    [目的] 研究不同剂量的重组人骨发生蛋白2(recombinant human bone morphogenetic protein-2,rhBMP-2)复合明胶海绵(Absorbable collagen sponge, ACS)修复兔桡骨极限骨缺损(critical size bone defect,CSD)的疗效及其量效关系。[方法] 将36只新西兰白兔按照随机数字表法随机分为12组,每组3只,制作新西兰白兔单侧桡骨中段15 mm的极限骨缺损实验模型,按下列分组给于处理:A~C组及D~F组为4周和8周实验组,各实验组按植入的rhBMP-2剂量分为低剂量实验组(0.25mg rhBMP-2+ACS, A/D组),中剂量实验组(0.5mgrhBMP-2+ACS, B/E组)、高剂量实验组(2.5mgrhBMP-2+ACS, C/F组); Ctr1a~ Ctr3a与Ctr1b~Ctr3b为4周及8周对照组,按处理方式分为空海绵对照组(ACS, Ctr1a/ Ctr1b)、空白对照组(Ctr2a/ Ctr2b)、植骨对照组(Ctr3a/ Ctr3b);术后4、8周取材行X线观察比较各组骨修复外观情况;行CT扫描及三维重建观察缺损区骨修复效果并定量分析各成骨相关指标;行组织切片HE染色观察各组新生骨成熟情况。[结果] X线、Micro-CT结果显示术后4及8周三个剂量组的桡骨缺损区域均有新生骨生成。相比而言,高剂量组 成骨效果最好,中剂量组次之,低剂量组最差,组间两两比较差异具有统计学意义(P<0.05);组织切片结果显示术后4周、8周高剂量组新生骨骨成熟度最好,中剂量组次之,低剂量组最差;空海绵组与空白组成果效果一致,均未见明显骨生长。[结论] rhBMP-2能促进兔桡骨极限骨缺损的修复;在0.25mg-2.5mg 范围内区,骨修复效果与rhBMP-2的剂量呈正相关。

    Abstract:

    Abstract [Objective] To study the effect of different doses of recombinant human bone morphogenetic protein-2 (rhBMP-2) combined with absorbable collagen sponge (ACS) in repairing critical size bone defect (CSD) of rabbit radius and its dose-effect relationship. [Methods] 36 New Zealand white rabbits were randomly divided into 12 groups with 3 rabbits in each group according to the random number table method, and the experimental model of 15mm critical bone defect in the middle radius of one side of New Zealand white rabbits was made and divided into the following groups for treatment: Groups A~C and D~F respectively were 4 and 8 weeks experimental groups, each experimental group was divided into low dose experimental group (0.25mg RHBMP-2 +ACS, A/D group), medium dose experimental group (0.5 MgrhbMP-2 +ACS, B/E group) and high dose experimental group (2.5 MgrhbMP-2 +ACS, C/F group) according to the implanted dose of RHBMP-2; Ctr1a-ctr3a and Ctr1b-Ctr3b respectively were 4 and 8 weeks control groups, which were divided into empty sponge control group (ACS, Ctr1a/ Ctr1b), blank control group (Ctr2a/ Ctr2b) and bone graft control group (Ctr3a/ Ctr3b) according to treatment methods. 4 and 8 weeks after surgery, X-ray was used to observe the appearance of bone repair in each group. Micro-CT scan and 3D reconstruction were performed to observe the effect of bone repair in the defect area and quantitatively analyze the osteogenesis related indicators. Tissue sections were stained with HE to observe the maturation of new bone in each group. [Results]: The general observation, X-ray and Micro-CT showed that new bone was formed in the radius defect area in the three dose groups at 4 and 8 weeks postoperatively.In comparison, the high dose group had the best osteogenesis effect, followed by the medium dose group, and the low dose group had the worst osteogenesis effect, and the pairwise comparison between groups had statistical significance (P<0.05).The results of tissue section showed that the new bone maturity was best in the high-dose group at 4 and 8 weeks after operation, followed by the medium-dose group and the low-dose group.The effect of the empty sponge group was the same as that of the blank group, and no obvious bone growth was observed. [Conclusion]: rhBMP-2 can promote the repair of rabbit radius critical bone defect; In the range of 0.25mg-2.5mg, the effect of bone repair was positively correlated with the dose of rhBMP-2.

    参考文献
    相似文献
    引证文献
引用本文
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2022-06-22
  • 最后修改日期:2022-09-11
  • 录用日期:2022-12-20
  • 在线发布日期:
  • 出版日期: